Serial analysis of circulating tumor cells identifies four prognostic groups for novel risk-stratification in metastatic breast cancer (CALGB 40502/NCCTG N063H) (Alliance)
- Citation:
- Meeting Instance:
- AACR-ALB 2020
- Year:
- 2020
- Type:
- Abstract
- Sub type:
- Oral
- Funding:
- NCTN
- Endpoint:
- Secondary
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Parents:
- None
- Children:
- 3179
- Program:
- TRP
- Primary Committee:
- Correl Sci NOS
- Sec. Committees:
- Pharmas:
- Bristol-Myers, Celgene
- Grants:
- U10CA180821, U10CA180882, U10CA138561, U10CA180791, U10CA180867, P30CA014236, Breast Cancer Research Foundation BCRF-17-140, U10CA180820 (ECOG-ACRIN);
- Corr. Author:
- Authors:
- Mark Jesus M. Magbanua Laura H. Hendrix Terry Hyslop William T. Barry Eric P. Winer Clifford Hudis Deborah Toppmeyer Lisa Anne Carey Anne Partridge Jean-Yves Pierga Tanja Fehm José Vidal-Martínez Dimitrios Mavroudis Jose A. Garcia-Saenz Justin Stebbing Paola Gazzaniga Luis Manso Rita Zamarchi María Luisa Antelo Leticia De Mattos-Arruda Daniele Generali Carlos Caldas Elisabetta Munzone Luc Dirix Amy L. Delson Harold Burstein Misbah Qadir Cynthia Ma Janet H. Scott François-Clément Bidard John W. Park Hope S. Rugo
- Networks:
- AURORA, CA824, LAPS-CT018, LAPS-MA036, LAPS-MO011, LAPS-NC007, LAPS-NY016, NC012
- Study
- CALGB-40502
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 3
- Keywords:
- circulating tumor cells, metastatic breast cancer, chemotherapy, prognosis, liquid biopsy